Evidence map›Paper›PMID 40843781›Full record

ReviewBiotech (Basel (Switzerland))2025

Pathway Analysis Interpretation in the Multi-Omic Era.

William G Ryan V, Smita Sahay, John Vergis, Corey Weistuch, Jarek Meller, Robert E McCullumsmith

Abstract readReview
In one paragraph

Review in Biotech (Basel (Switzerland)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. A practical guide to functional enrichment analysis.Frontiers in bioinformatics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

William G Ryan VDepartment of Neurosciences and Psychiatry, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43606, USA.ORCID 0000-0003-4868-4002
Smita SahayDepartment of Neurosciences and Psychiatry, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43606, USA.ORCID 0009-0003-4377-8963
John VergisDepartment of Neurosciences and Psychiatry, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43606, USA.ORCID 0009-0006-0864-3264
Corey WeistuchDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jarek MellerDepartment of Environmental and Public Health Sciences, University of Cincinnati, Cincinnati, OH 45221, USA.
Robert E McCullumsmithDepartment of Neurosciences and Psychiatry, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43606, USA.ORCID 0000-0001-6921-7150

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Translational assessment of brain bioenergetic function in schizophreniaR01MH121102 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI MARANO, CHRISTOPHER, MCCULLUMSMITH, ROBERT E · 2020 to 2024
$3.7M
Investigation of active kinome networks in Alzheimer's dementia.R01AG083628 · NIA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI JAREK MELLER, Robert E McCullumsmith · 2024 to 2026
$2.3M
Development of Attenuated Furoxans as Novel Therapies for Alzheimer's DiseaseR01AG057598 · NIA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SCHIEFER, ISAAC T · 2018 to 2022
$2.3M
Cell-specific analysis of sub-kinomes in schizophreniaR01MH107487 · NIMH · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI MCCULLUMSMITH, ROBERT E, MELLER, JAREK · 2016 to 2020
$1.9M
Training in Molecular and translational Cell DynamicsT32GM144873 · NIGMS · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI AVIDOR-REISS, TOMER, DWORKIN, LANCE DOUGLAS · 2022 to 2024
$1.3M
NCI NIH HHS P30 CA008748NIA NIH HHS R01 AG057598NIA NIH HHS R01 AG083628NIGMS NIH HHS T32 GM144873NIH HHS 1T32GM144873-01NIH HHS R01AG057598NIH HHS R01AG083628NIH HHS R01MH107487NIH HHS R01MH121102NIMH NIH HHS R01 MH107487NIMH NIH HHS R01 MH121102
6 · The paper itself

Abstract

In bioinformatics, pathway analyses are used to interpret biological data by mapping measured molecules with known pathways to discover their functional processes and relationships. Pathway analysis has become an essential tool for interpreting large-scale omics data, translating complex gene sets into actionable experimental insights. However, issues inherent to pathway databases and misinterpretations of pathway relevance often result in "pathway fails," where findings, though statistically significant, lack biological applicability. For example, the Tumor Necrosis Factor (TNF) pathway was originally annotated based on its association with observed tumor necrosis, while it is multifunctional across diverse physiological processes in the body. This review broadly evaluates pathway analysis interpretation, including embedding-based, semantic similarity-based, and network-based approaches to clarify their ideal use-case scenarios. Each method for interpretation is assessed for its strengths, such as high-quality visualizations and ease of use, as well as its limitations, including data redundancy and database compatibility challenges. Despite advancements in the field, the principle of "garbage in, garbage out" (GIGO) shows that input quality and method choice are critical for reliable and biologically meaningful results. Methodological standardization, scalability improvements, and integration with diverse data sources remain areas for further development. By providing critical guidance with contextual examples such as TNF, we aim to help researchers align their objectives with the appropriate method. Advancing pathway analysis interpretation will further enhance the utility of pathway analysis, ultimately propelling progress in systems biology and personalized medicine.

Indexed as

embeddingsgene ontologyomics interpretationpathway analysissemantic similarity

Identifiers

PMID40843781
PMCPMC12372084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.